Our Industrial Partners

Our industrial partner group represent a wide array of Scandinavian pharma and biotech companies. The companies provide SweDeliver with broad scientific and industrial competence and experience.

Affibody AB

Affibody logotype

Affibody is a clinical stage Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. Affibody is developing a portfolio of innovative drug projects and, in addition, offers the half-life extension technology, Albumod™, for outlicensing.

Affibody AB online

Apotek Produktion & Laboratorier AB

APL logotype

APL is one of the leading manufacturers of extempore pharmaceutical drugs in Europe, one of the leading contract manufacturer in Life Science in Scandinavia and an established partner to pharmacies for services and products. With 580 employees and four production plants, APL have resources for developing, analysing and producing medical products that improve or save lives.

APL online

AstraZeneca R&D

AstraZeneca logotype

AstraZeneca is a global, science-led biopharmaceutical business bringing innovative medicines to millions of patients. Our Gothenburg site is one of AstraZeneca's three strategic science centres. There we focus on cardiovascular/metabolic, respiratory diseases, strongly underpinned by drug delivery R&D.

AstraZeneca Gothenburg online

CTC – Clinical Trial Consultants AB

CTC logtype

CTC AB is a Swedish full-service CRO with clinical conduct in focus. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice and implementation of early clinical trials (Phase 0 / I / IIa). CTC has three dedicated research clinics in Sweden, of which one is located at the Uppsala University Hospital, specialised in first time in human studies.

CTC online

DelSiTech

DelSiTech logotype

DelSiTech is an innovative drug delivery and development company that works with its partners to turn their active agents into novel and commercially attractive therapeutic drug products. DelSiTech provides the technology and expertise for solving drug delivery problems. The company’s technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over other technologies.

DelSiTech online

Disruptive Materials AB

Disruptive Materials logotype

Disruptive Materials has developed a unique and patented mesoporous magnesium carbonate, Upsalite®, that can be used as a drug delivery system for poorly soluble drugs. Upsalite enables drugs to be loaded in an amorphous form into its’ nanometer sized pores. We have demonstrated high drug load and amorphous stability over time for several drugs.

Disruptive Materials online

Emplicure AB

Emplicure logotype

Emplicure AB is a privately held Swedish research and product development focused pharmaceutical company. We develop new patentable pharmaceutical products based on drug delivery platform technologies originating from the interface between the materials and pharmaceutical sciences. Our products are all based on a large unmet medical need and existing pharmaceutical ingredients.

Emplicure online

Ferring Pharmaceuticals A/S

Ferring Pharmaceuticals logotype

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology.

Ferring Pharmaceuticals online

ICONOVO AB

ICONOVO AB logotype

Iconovo is an innovative Swedish company that develops state-of the-art inhalation devices for licensing to customers. Every device is based on our proprietary platform but customized and adapted to the customer’s unique needs and requirements.

Iconovo online

Janssen Pharmaceuticals

Janssen Pharmaceuticals, founded in 1953 is headquartered in Beerse, Belgium. Owned by Johnson & Johnson, Janssen is today one of the world’s leading research-based pharmaceutical companies, conducting research and development activities related to a wide range of human medical disorders.

Janssen Pharmaceuticals online

MVIC AB

MVIC AB logotype

MVIC is a full service CRO and partner specializing in inhaled drug delivery. Comprised of 26 Swedish member companies with long experience and high quality expertize in all aspects of inhalation product development.

MVIC online

Nanologica AB

Nanologica AB logotype

Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science.

Nanologica online

Orexo AB

Orexo AB logotype

Orexo is a fully integrated specialty pharmaceutical company that develops improved pharmaceuticals based on innovative drug delivery technologies. Commercially the current focus is to help patients suffering from opioid dependence and pain while the research and development primarily is concentrated around addiction. The products are commercialized by Orexo in the US or via selected partners worldwide.

Orexo online

Orion Pharma

Orion Pharma logotype

Orion Pharma is a globally operating Finnish pharmaceutical company who develops, manufactures and markets human and veterinary pharmaceuticals and APIs. Therapies targets central nervous system disorders, oncology and respiratory diseases.

Orion Pharma online

Pharmetheus

Pharmetheus logotype

Pharmetheus offers pharmacometric services supporting drug development of compounds in all clinical phases and in all therapeutic areas. Pharmetheus leverage on recent advances in model-based drug development methodology.

Pharmetheus online

Ultimovacs AB

Ultimovacs AB logotype

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Ultimovacs online

Last modified: 2022-05-17